For-Robin, Inc.

Our patented JAA-F11 antibody is a targeted immunotherapy for primary and metastatic breast cancer including triple negative subtypes, meeting an unmet need.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Williamsville, NY, US
  • Currency USD
  • Founded January 2012
  • Employees 7
  • Incorporation Type S-corp
  • Website for-robin.com

Company Summary

For-Robin,Inc named in honor of the founder's sister who died at age 31 of breast cancer (BrCa), is an antibody immunotherapy company whose primary mission is developing treatments for BrCa patients. Our patented monoclonal antibody, JAA-F11 targets all BrCa cell subtypes including triple negative BrCa where no targeted therapy currently exists addressing the critical need for safe and effective treatment for primary and metastatic BrCa.

Team

  • Kate Rittenhouse-Olson

  • Sally A. Quataert, Ph.D., RQAP-GLP
    Chief Executive Officer

    > 25 years experience in pharmaceutical and diagnostic industry
    > 12 years experience in academics in Clinical Translational Research Studies
    > 12 years experience as President, Compliant Systems Integration, Inc. in quality and regulatory consulting
    Ph.D. in Microbiology and Immunology with focus in Tumor Immunology
    Registered Quality Assurance professional in Good Laboratory Practices

  • James Olson, Ph.D.
    Vice President

    Distinguished Professor SUNY at Buffalo
    >20 years experience in toxicologyconsulting

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free